Explain this page
Arphra AIPlain-English read on Corbus Pharmaceuticals Holdings, Inc.’s valuationNo recent stories.
today
- Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences38d
- Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences38d
- Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update39d
- Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update39d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $38.50 (+366.10%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.61% | -0.60% | -15.11% | -3.95% | +1.72% | +1.47% | +0.24% | +14.25% | -86.09% | -90.76% | -90.82% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$8.20
1 sh
Bid
$7.77
1 sh
Ask
$8.62
2,147 sh
Spread
$0.850
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Corbus Pharmaceuticals to Participate in Upcoming Investor Conferencesglobenewswire.com·May 13, 2026
- Corbus Pharmaceuticals to Participate in Upcoming Investor Conferencesglobenewswire.com·May 13, 2026
- Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Updateglobenewswire.com·May 12, 2026
- Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Updateglobenewswire.com·May 12, 2026
Recent analyst activity
DB- Jun 17, 2026GradeOutperform → OutperformCorbus Pharmaceuticals (CRBP) PT Lowered to $52 at OppenheimerOppenheimer
Peers
No peer list available for CRBP.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|